Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Classification of current anticancer immunotherapies.

Lorenzo Galluzzi | Erika Vacchelli | José-Manuel Bravo-San Pedro | Aitziber Buqué | Laura Senovilla | Elisa Elena Baracco | Norma Bloy | Francesca Castoldi | Jean-Pierre Abastado | Patrizia Agostinis | Ron N Apte | Fernando Aranda | Maha Ayyoub | Philipp Beckhove | Jean-Yves Blay | Laura Bracci | Anne Caignard | Chiara Castelli | Federica Cavallo | Estaban Celis | Vincenzo Cerundolo | Aled Clayton | Mario P Colombo | Lisa Coussens | Madhav V Dhodapkar | Alexander M Eggermont | Douglas T Fearon | Wolf H Fridman | Jitka Fučíková | Dmitry I Gabrilovich | Jérôme Galon | Abhishek Garg | François Ghiringhelli | Giuseppe Giaccone | Eli Gilboa | Sacha Gnjatic | Axel Hoos | Anne Hosmalin | Dirk Jäger | Pawel Kalinski | Klas Kärre | Oliver Kepp | Rolf Kiessling | John M Kirkwood | Eva Klein | Alexander Knuth | Claire E Lewis | Roland Liblau | Michael T Lotze | Enrico Lugli | Jean-Pierre Mach | Fabrizio Mattei | Domenico Mavilio | Ignacio Melero | Cornelis J Melief | Elizabeth A Mittendorf | Lorenzo Moretta | Adekunke Odunsi | Hideho Okada | Anna Karolina Palucka | Marcus E Peter | Kenneth J Pienta | Angel Porgador | George C Prendergast | Gabriel A Rabinovich | Nicholas P Restifo | Naiyer Rizvi | Catherine Sautès-Fridman | Hans Schreiber | Barbara Seliger | Hiroshi Shiku | Bruno Silva-Santos | Mark J Smyth | Daniel E Speiser | Radek Spisek | Pramod K Srivastava | James E Talmadge | Eric Tartour | Sjoerd H Van Der Burg | Benoît J Van Den Eynde | Richard Vile | Hermann Wagner | Jeffrey S Weber | Theresa L Whiteside | Jedd D Wolchok | Laurence Zitvogel | Weiping Zou | Guido Kroemer
Oncotarget | 2014

During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for use in cancer patients, and many others are being investigated as standalone therapeutic interventions or combined with conventional treatments in clinical studies. Immunotherapies may be subdivided into "passive" and "active" based on their ability to engage the host immune system against cancer. Since the anticancer activity of most passive immunotherapeutics (including tumor-targeting monoclonal antibodies) also relies on the host immune system, this classification does not properly reflect the complexity of the drug-host-tumor interaction. Alternatively, anticancer immunotherapeutics can be classified according to their antigen specificity. While some immunotherapies specifically target one (or a few) defined tumor-associated antigen(s), others operate in a relatively non-specific manner and boost natural or therapy-elicited anticancer immune responses of unknown and often broad specificity. Here, we propose a critical, integrated classification of anticancer immunotherapies and discuss the clinical relevance of these approaches.

Pubmed ID: 25537519 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000430
  • Agency: NCI NIH HHS, United States
    Id: P30 CA010815
  • Agency: NCI NIH HHS, United States
    Id: P50 CA121973
  • Agency: NCI NIH HHS, United States
    Id: P30 CA008748
  • Agency: NCI NIH HHS, United States
    Id: R01 CA109542

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ClinicalTrials.gov (tool)

RRID:SCR_002309

Registry and results database of federally and privately supported clinical trials conducted in United States and around world. Provides information about purpose of trial, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.Offers information for locating federally and privately supported clinical trials for wide range of diseases and conditions. Research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings. ClinicalTrials.gov contains trials sponsored by National Institutes of Health, other federal agencies, and private industry. Studies listed in database are conducted in all 50 States and in 178 countries.

View all literature mentions

U.S. Food and Drug Administration (tool)

RRID:SCR_012945

An agency of the United States Department of Health and Human Services, one of the United States federal executive departments that is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics and veterinary products. The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction. (Wikipedia)

View all literature mentions